Co-administration of FGF-21 and GLP-1 to treat diabetes and lower blood glucose

• 收藏
• 分享

专利权人:

Tamer Coskun;Wolfgang Glaesner

发明人:

Tamer Coskun,Wolfgang Glaesner

申请号：

US13534322

公开号：

US08557769B2

申请日:

2012.06.27

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present invention provides methods of lowering body weight by administering an FGF-21 compound in combination with a GLP-1 compound. In addition, the present invention also provides methods to treat obesity by administering an FGF-21 compound in combination with a GLP-1 compound. The present invention also discloses combinations useful in the methods of the present invention.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/